Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily E Scott

Showing results (11-20 of 85) with videos related to

Pageof 9
Sort By:
Nature|January 24, 2012
Structures of cytochrome P450 17A1 with prostate cancer drugs abiraterone and TOK-001Natasha M DeVore, Emily E Scott
The Journal of Biological Chemistry|October 29, 2017
Structural and functional effects of cytochrome <i>b</i><sub>5</sub> interactions with human cytochrome P450 enzymesAaron G Bart, Emily E Scott
The Journal of Biological Chemistry|July 30, 2025
Cytochrome P450 2W1: Identification of new inhibitors, active site ligands, and pharmacophoresElyse K Frydendall, Emily E Scott
The Journal of Biological Chemistry|July 30, 2023
Allosteric modulation of cytochrome P450 enzymes by the NADPH cytochrome P450 reductase FMN-containing domainSarah D Burris-Hiday, Emily E Scott
Molecular and Cellular Endocrinology|March 30, 2021
Steroidogenic cytochrome P450 17A1 structure and functionSarah D Burris-Hiday, Emily E Scott
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|September 4, 2008
Expression, purification, crystallization and preliminary X-ray studies of a prolyl-4-hydroxylase protein from Bacillus anthracisMegen A Miller, Emily E Scott, Julian Limburg
Biochemistry|December 2, 2009
Crystal structure of prolyl 4-hydroxylase from Bacillus anthracisMegen A Culpepper, Emily E Scott, Julian Limburg
The Journal of Biological Chemistry|August 9, 2022
The structure and characterization of human cytochrome P450 8B1 supports future drug design for nonalcoholic fatty liver disease and diabetesJinghan Liu, Heather A Carlson, Emily E Scott
The Journal of Biological Chemistry|September 27, 2008
Structures of human cytochrome P-450 2E1. Insights into the binding of inhibitors and both small molecular weight and fatty acid substratesPatrick R Porubsky, Kathleen M Meneely, Emily E Scott
Chemical Research in Toxicology|November 20, 2002
Substrate routes to the buried active site may vary among cytochromes P450: mutagenesis of the F-G region in P450 2B1Emily E Scott, You Qun He, James R Halpert
Pageof 9

Showing results (11-20 of 85) with videos related to

Sort By:
Pageof 9
Nature|January 24, 2012
Structures of cytochrome P450 17A1 with prostate cancer drugs abiraterone and TOK-001Natasha M DeVore, Emily E Scott
The Journal of Biological Chemistry|October 29, 2017
Structural and functional effects of cytochrome <i>b</i><sub>5</sub> interactions with human cytochrome P450 enzymesAaron G Bart, Emily E Scott
The Journal of Biological Chemistry|July 30, 2025
Cytochrome P450 2W1: Identification of new inhibitors, active site ligands, and pharmacophoresElyse K Frydendall, Emily E Scott
The Journal of Biological Chemistry|July 30, 2023
Allosteric modulation of cytochrome P450 enzymes by the NADPH cytochrome P450 reductase FMN-containing domainSarah D Burris-Hiday, Emily E Scott
Molecular and Cellular Endocrinology|March 30, 2021
Steroidogenic cytochrome P450 17A1 structure and functionSarah D Burris-Hiday, Emily E Scott
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|September 4, 2008
Expression, purification, crystallization and preliminary X-ray studies of a prolyl-4-hydroxylase protein from Bacillus anthracisMegen A Miller, Emily E Scott, Julian Limburg
Biochemistry|December 2, 2009
Crystal structure of prolyl 4-hydroxylase from Bacillus anthracisMegen A Culpepper, Emily E Scott, Julian Limburg
The Journal of Biological Chemistry|August 9, 2022
The structure and characterization of human cytochrome P450 8B1 supports future drug design for nonalcoholic fatty liver disease and diabetesJinghan Liu, Heather A Carlson, Emily E Scott
The Journal of Biological Chemistry|September 27, 2008
Structures of human cytochrome P-450 2E1. Insights into the binding of inhibitors and both small molecular weight and fatty acid substratesPatrick R Porubsky, Kathleen M Meneely, Emily E Scott
Chemical Research in Toxicology|November 20, 2002
Substrate routes to the buried active site may vary among cytochromes P450: mutagenesis of the F-G region in P450 2B1Emily E Scott, You Qun He, James R Halpert
Pageof 9